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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S395collinearity (r > 0.80). Third, Spearman correlation coefﬁcient was
calculated between each exploratory behavior variable and the group
variable. Where collinearity occurred, the variable most correlated with
the group variable was selected for entry into logistic regression. Fourth,
during logistic regression the forward stepwise method was used, eight
exploratory behavior variables were entered as predictors of study
group allocation. Signiﬁcance was tested at two-tailed p < 0.05.
Results: Micro-CT conﬁrmed knee OA in the OA rat model. Weight
bearing had a signiﬁcant main effect by study group (F(1,9)¼24.591 ,
p¼0.001). Percent weight bearing by the right hind limb was sig-
niﬁcantly different between the groups at week two, six, and eight post-
surgery, but not at week four. Exploratory behavior variables showed no
main effect by group, nine variables had a main effect by time, of which
three variables had an interaction effect. Parsing these interaction
effects reveal no signiﬁcant difference in ambulatory episodes between
groups at each time point. The OA rat model had more ambulatory
episodes at week four, which was not statistically signiﬁcant (p ¼
0.062). Vertical episodes were consistently lower for the OA rat model,
but statistically signiﬁcant only at week four. Counter-clockwise revo-
lution was not statistically signiﬁcant between groups at each time
point, but was signiﬁcant by time within the OA group. Logistic
regression revealed weight bearing and only these same three explor-
atory variables (ambulatory episode, vertical episode, and counter-
clockwise revolution) were signiﬁcant predictors of study group status
(see table 1).
Conclusions: This knee OA rat model was symptomatic in terms of
pain-related and exploratory behavior. This study showed that weight
bearing and three exploratory behavior variables may be useful out-
come measures in the preclinical pharmacological studies with this
knee OA rat model. However, evaluation of exploratory behavior for
longer periods would be more consistent with some other studies, and
might increase power to detect statistical signiﬁcance.Association of Exploratory Behavior Variables with study group status
Variable B* P value Sham vs OA modelOdd Ratio
Ambulatory Episode -.171 0.037 0.842
Vertical Episode .109 0.004 1.115
Counter Clockwise Revolution -.218 0.018 0.804
*Negative sign means as counts increased in the knee osteoarthritis group, they
decreased in the sham group.702
ROLE OF PLATELETS IN THE PATHOGENESIS OF OSTEOARTHRITIS
AND BIOLOGICAL EFFECTS OF HYALURONIC ACID: IN VIVO AND IN
VITRO STUDY
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Purpose: Although osteoarthritis (OA) is a degenerative joint disorder,
it has been demonstrated that inﬂammation takes part in the devel-
opment and progression of this condition. Matrix metalloproteinases
(MMPs), including MMP-2, are involved in the cartilage breakdown
observed in OA. Platelets (PLTs) are involved in different inﬂammatory
conditions, including rheumatoid arthritis, contain and release several
MMPs, including MMP-2, and enhance MMPs expression by other cell
types. However, their role in OA has not been investigated yet. Hya-
luronic acid (HA) is a normal component of extracellular matrix and
synovial ﬂuid (SF). Intra-articular (IA) administration of HA in OA is
widely employed in clinical practice with good clinical efﬁcacy. Aims of
our study were to investigate the role of platelets and MMP-2 in the
pathogenesis of OA, to test the biologic activity of IA-HA in OA patients
and to analyze the effects of HA on the interaction between platelets
and synoviocytes in vitro.
Methods: Thirty-eight patients with knee OA were screened and
twenty-four patients were included in the study. Systemic therapy with
non-steroidal anti-inﬂammatory drugs or corticosteroids and previous
IA corticosteroid treatment represented exclusion criteria. Five injec-
tions of IA sodium hyaluronate (500-730 KDa) were administrated
weekly. SF samples were collected prior to the ﬁrst (T0) and at the last(T1) injection. Total cell and PLT count, platelet-leukocyte aggregates
(PLT activation marker) and MMP-2 levels were measured in SF. For
clinical assessment at T0, T1 and 3 months after the last injection (T3)
the Western Ontario and Mc Masters University (WOMAC) scale and
VAS for knee pain were employed.
Fibroblast-like synoviocytes (FLS) were isolated from untreated OA-SF
and cultured with PLTs in presence or absence of HA at different con-
centrations for 24 hours. Platelet P-selectin was measured by ﬂow-
cytometry and MMP-2 in culture supernatants was quantiﬁed by
zymography.
Results: Total cell count in SF was signiﬁcantly reduced after IA-HA
(p<0.05). PLT count, platelet-leukocyte aggregates and MMP-2 con-
centration were signiﬁcantly decreased at T1 (all p<0.05). WOMAC
scale and pain VAS were reduced at T1 (p<0.0001) and this decrease
was maintained at T3. MMP-2 production by FLS was signiﬁcantly
higher in the presence of PLTs and this increase was signiﬁcantly
reduced by co-incubation with HA. P-selectin expression, marker of PLT
activation, was signiﬁcantly higher in PLTs cultured with FLS and P-
selectin blockade reduced MMP-2 release in culture supernatants.
Conclusions: Our results show that PLTs, in addition to other inﬂam-
matory cells, participate in the pathogenesis of OA by the induction of
MMP-2 release by FLS possibly via P-selectin, thus contributing to
cartilage breakdown. Treatment with HA decreases count and activa-
tion of PLT and levels of MMP-2 in the SF. PLT and synoviocytes inter-
action leads to platelet activation and MMP-2 release enhancement.
Hence, PLTs may represent a new therapeutic target in OA.
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REPLICATION STUDY TO IDENTIFY CLINICALLY RELEVANT
PHENOTYPES FROM A KNEE OSTEOARTHRITIS POPULATION: DATA
FROM THE AMSTERDAM OSTEOARTHRITIS COHORT
J. Knoop y, L.D. Roorda y, M. van der Leeden y,z, M. van der Esch y,
D.L. Knol z, W.F. Lems y,z, J. Dekker z. yReade, center for rehabilitation and
rheumatology, Amsterdam, Netherlands; zVU Univ. Med. Ctr., Amsterdam,
Netherlands
Purpose: We previously identiﬁed 5 clinically relevant phenotypes
from a heterogeneous knee OA population (Osteoarthritis Initiative
[OAI] cohort). The present study aims to replicate this phenotype
identiﬁcation for validation in a clinical setting using data from the
Amsterdam Osteoarthritis (AMS-OA) cohort.
Methods: K-means clustering analysis was performed in 374 knee OA
patients from the AMS-OA cohort, using 4 clinically relevant and easily
obtainable patient characteristics or clustering variables: radiographic
severity (Kellgren/Lawrence [K/L]grade), bodymass index (BMI),upper leg
muscle strength, and depression (from Hospital Anxiety and Depression
Scale [HADS] questionnaire). The cluster solutionwith the highest Pseudo
F value was considered the most adequate number of clusters or pheno-
types in the dataset. This solution was compared with the original study.
Results: The most adequate number of phenotypes was 5, similar as in
the original study. Moreover, the 5 identiﬁed phenotypes represented in
general similar phenotypes compared to the original study, namely a
‘minimal joint disease phenotype’, a ‘strong muscle phenotype’, a ‘non-
obese weak muscle phenotype’ (although obesity was more prevalent
compared to the original study), an ‘obeseweakmuscle phenotype’, and
a ‘depressive phenotype’ (although depression was less prevalent
compared to the original study).
Conclusions: The identiﬁcation of phenotypes from the OAI cohort
could be replicated, except for two minor differences that are pre-
sumably attributable to differences in study population. The phenotype
identiﬁcation seems therefore a valid ﬁnding, with phenotypes possibly
representing different etiological subtypes of knee OA in which phe-
notype-speciﬁc interventions may be needed.
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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S396Purpose: To examine the associations of elevated serum c-reactive
protein (CRP) and erythrocyte sedimentation rate (ESR) with radio-
graphic progression in patients with established knee osteoarthritis
(OA), over two years.
Methods: Data from 186 patients with knee OA were gathered at
baseline and at two-years follow up. CRP (mg/l) and ESR (mm/l) were
measured in serum from patients’ blood. Inﬂammatory markers were
considered elevated if CRP>3mg/l or ESR20mm/h (1). Radiographs of
the knees were used to assess joint space narrowing (JSN), ostephytes,
sclera and cysts in the tibiofemoral (medial and lateral) and patellofe-
moral compartments, Kellgren and Lawrence (KL) score (0-4) was also
determined. Progression was deﬁned as an increase in 1 in the
radiographic features assessed or total KL score in either knee during
follow-up. The association of inﬂammatory markers with radiographic
progression was analyzed using uni- and multivariate linear regression
models. Full models were adjusted for age, gender, NSAIDs use, BMI
change, comorbidities change and higher radiographic feature or KL
score at baseline.
Results: Patients with elevated CRP and ESR values at both baseline and
two-years follow-up exhibited no progression in KL score compared
with the group with not elevated values at both times of assessment,
before or after adjustment for relevant confounders. When analyzing
the various futures (JSN, ostephytes, sclera and cysts),a signiﬁcant
association was found only between elevated CRP (OR¼2.9, p¼0.048)
and ESR (OR¼4.42, p¼0.017) values at both times of assessment and JSN
progression in the patellofemoral compartment compared with the
group with not elevated levels. No association was found between
elevated values of CRP and ESR at baseline and at follow-up with
radiographic progression of the other features analyzed in the three
compartments assessed.
Conclusions: Overall this study provides no evidence that persistently
elevated CRP and ESR values are related to a radiographic progression in
patients with established knee OA, over two years. Our results are in
line with previous evidence which has suggested no association
between elevated inﬂammatory markers and progression of OA (2).
Future studies should be performed analyzing this association with
local markers of inﬂammation, instead of systemic inﬂammatory
markers. Additionally, considering the slow progression of the disease, a
longer follow-up period might be recommended.
Reference List
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SHOE TORSIONAL RESISTANCE RELATED TO MEDIAL KNEE OA
R.H. Lidtke, N. Shakoor, M. Wimmer, J.A. Block. Rush Univ. Med. Ctr.,
Chicago, IL, USA
Purpose: Recent evidence suggests that footwear can signiﬁcantly
affect dynamic knee loading and that ﬂat, ﬂexible shoes may result in
lower knee loads compared to more supportive, stiff-soled shoes. Here,
we evaluate the torsional stiffness of the shoe compared longitudinal
effects on knee loading over 6 months.
Methods: Subjects with radiographic (KL grades  2) and symptomatic
(at least 30mm pain of 100mm scale while walking) medial compart-
ment knee OAwere recruited and randomized to receive a ﬂexible soled
shoe (mobility shoe) or identical appearing “control” shoe with stiffer
sole. The frontal plane torsional stiffness of the shoe was evaluated
using a biomaterial testing system. Investigators and participants were
blinded to shoe assignment. Baseline gait analyses were performed
using an optoelectronic camera system and multi-component force
plate in subjects’ “own shoes”, study shoes, and barefoot. Subjects were
instructed to wear the study shoes at least 6 hours/day for 6 days/week.
Gait analysis was repeated at 6, 12 and 24 weeks. The peak knee
adduction moment (KAM), a validated marker of medial compartment
loading, was evaluated. An intent-to-treat analysis was performed with
imputation of missing data using a hot deck method (Rubin, 1987).
Repeated measures analysis of variance compared the two arms andplanned contrasts were used to further analyze the data and load
reductions at various time points.
Results: 22 participants (13 women, mean age 557 years) were
assigned to the mobility shoe and 28 (21 women, mean age 558 years)
to the control shoe. The median modulus of elasticity of the treatment
group shoes was 0.250.07 compared to the control shoe 0.941.05
(p¼0.009). There was a strong correlation between the reduction in the
KAM and torsional stiffness from baseline to 24 months in treatment
group and control group (0.88 and 0.89 respectively p¼0.03) There
were differences in Peak KAM over time in the treatment group vs.
control with the more ﬂexible shoe producing reductions while the
control increased moments (-0.25 0.95 and 0.09 0.95 %BW*ht
respectively, rmANOVA, p¼0.002).
Conclusions: This double-blind randomized controlled trial suggests
that loading of the medial knee is directly related to the torsional
stiffness the shoe. The use of shoes with ﬂexibility in the frontal plane
over 6 months results in signiﬁcant reductions in medial knee loading
compared to stiffer shoes with greater torsional resistance. Thus, eval-
uating the shoe for torsional resistance may help determine which shoe
would be an effective biomechanical intervention for the management
of knee OA.
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INTRA-ARTICULAR INJECTION THERAPY FOR PATIENTS WITH HIP
OSTEOARTHRITIS. A SYSTEMATIC REVIEW OF THE LITERATURE
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Purpose: In current systematic review we will compare the efﬁcacy of
several intra-articular treatment options (CS, HA, PRP and placebo) in
patients with hip OA. The goal of this review is to give recom-
mendations regarding the most optimal treatment(s) of these patients
and formulate some recommendations for future research.
Methods: The following databases were searched: MEDLINE (period
1966 to June 2013), Cochrane Database of Systematic Reviews (1988 to
June 2013), Cochrane Clinical Trial Register (1988 to June 2013), EMBASE
(January 1988 to June 2013) and the WHO clinical trial register to
identify all articles concerning the intra-articular injection therapy for
hip OA.Search term (‘Hyaluronic Acid/administration and dosage’
[MeSH] OR ‘Hyaluronic Acid/diagnostic use’ [MeSH] OR ‘Hyaluronic
Acid/therapeutic use’ [MeSH] OR ‘Hyaluronic Acid/therapy’ [MeSH]) OR
corticosteroids OR platelet rich plasma OR stem cells AND hip)
Results: Of the 1781 studies found using the search terms mentioned
above, 36 were screened for eligibility. We included 10 RCTs (1 com-
pared CS and HA, the other compared CS or HA with different amounts
of CS, with other brands of HA, placebo and/or intra-articular admin-
istered anaesthetics) and 26 cohort series (23 HA, 1 CS ,2 PRP). Most
studies determined the efﬁcacy of intra-articular administered HA (29
papers). The efﬁcacy of intra-articular CS and PRP were studied in 7 and
2 papers, respectively. No studies were found about the use of intra-
articular mesenchymal stem cells or other treatments in patients with
hip OA. In 6 studies the results of patient treated with placebo were
reported. Of the 36 available studies 32 could be used to calculate the
effect sizes. Only the effect sizes of the treatments reported in the
studies of Flanagan et al and Migilore et al (2005) could not be calcu-
lated due to the lack of reporting data. The study of Conrozier et al
(2009) could not be used for pooling due to different durations of fol-
low-up of the patients and the study of Conrozier et al (2006) showed
the results of the same patients reported in the study of Conrozier et al
(2003). The treatment results of a total of 1979 patients could be used in
this review (499 CS, 1261 HA, 159 placebo and 60 PRP).In ﬁgure 1-4 the
calculated effect sizes of the different treatments, including placebo, at
different follow-up are shown.
Pooling the data of the different treatment options showed besides a
large heterogeneity regarding product of treatment, treatment regime
and outcome parameters also different follow-up time-points. For this
reason we decided to combine time-points 4 and 6 weeks and 8 and 12
weeks. Using these periods of follow-up we were able to compare the
effect sizes of the different treatments as shown in table 1 and 2.
Conclusion: Comparing the efﬁcacies of different treatments in
patients with hip OA at 4-6 weeks and 8-12 weeks we showed no
statistical differences. The differences in efﬁcacy between the treatment
